000650 Stock Overview
Produces and sells pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Renhe Pharmacy Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.87 |
| 52 Week High | CN¥7.42 |
| 52 Week Low | CN¥5.09 |
| Beta | 0.53 |
| 11 Month Change | -1.51% |
| 3 Month Change | 9.51% |
| 1 Year Change | -16.97% |
| 33 Year Change | -30.94% |
| 5 Year Change | -0.84% |
| Change since IPO | -21.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 000650 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.3% | -0.6% | -2.8% |
| 1Y | -17.0% | -8.7% | 2.0% |
Return vs Industry: 000650 underperformed the CN Pharmaceuticals industry which returned -7.9% over the past year.
Return vs Market: 000650 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
| 000650 volatility | |
|---|---|
| 000650 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 000650 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000650's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 5,792 | Wujun Huang | www.renheyaoye.com |
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in 1996 and is headquartered in Nanchang, China.
Renhe Pharmacy Co.,Ltd Fundamentals Summary
| 000650 fundamental statistics | |
|---|---|
| Market cap | CN¥8.13b |
| Earnings (TTM) | CN¥442.56m |
| Revenue (TTM) | CN¥4.36b |
18.4x
P/E Ratio1.9x
P/S RatioIs 000650 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000650 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.36b |
| Cost of Revenue | CN¥2.78b |
| Gross Profit | CN¥1.58b |
| Other Expenses | CN¥1.14b |
| Earnings | CN¥442.56m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 36.22% |
| Net Profit Margin | 10.14% |
| Debt/Equity Ratio | 0% |
How did 000650 perform over the long term?
See historical performance and comparison